The Oncology Institute, Inc. TOI Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on trailing twelve months.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s return on equity?
- The Oncology Institute, Inc. (TOI) reported return on equity of -277.6% in Q1 2025.
- How has The Oncology Institute, Inc.'s return on equity changed year-over-year?
- The Oncology Institute, Inc.'s return on equity decreased by 165.8% year-over-year, from -104.4% to -277.6%.
- What is the long-term trend for The Oncology Institute, Inc.'s return on equity?
- Over 3 years (2020 to 2024), The Oncology Institute, Inc.'s return on equity has grown at a 73.7% compound annual growth rate (CAGR), from -40.7% to -213.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.